Literature DB >> 15679831

A novel microdeletion syndrome with loss of the MSH2 locus and hereditary non-polyposis colorectal cancer.

E Lucci-Cordisco1, M Zollino, S Baglioni, I Mancuso, R Lecce, F Gurrieri, A Crucitti, L Papi, G Neri, M Genuardi.   

Abstract

Constitutional chromosome deletions can predispose to the development of cancer with the phenotypic characteristics of inherited cancer syndromes, when the deleted region encompasses a tumour suppressor gene. Examples of such conditions are represented by the cytogenetic deletions associated with retinoblastoma, Wilms tumour and familial adenomatous polyposis. So far, no constitutional deletions involving the genes implicated in hereditary non-polyposis colorectal cancer (HNPCC) have been identified. This may be at least partially because of the lack of distinctive phenotypic manifestations in HNPCC. We describe the first case of a constitutional microdeletion associated with HNPCC. Suspicion of a microdeletion was prompted by the association of mental retardation, postnatal growth deficiency, minor congenital anomalies and early onset (37 years) sporadic colon cancer. The patient was found to harbour a microdeletion within chromosome 2p16-p21, including the MSH2 gene. Since there are very few reports of deletions of the 2p16-p21 region, our observation sets the grounds for the definition of a novel multiple congenital anomaly/mental retardation/cancer microdeletion syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15679831     DOI: 10.1111/j.1399-0004.2004.00390.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  3 in total

Review 1.  Contiguous gene deletion of chromosome 2p16.3-p21 as a cause of Lynch syndrome.

Authors:  Erin E Salo-Mullen; Patricio B Lynn; Lu Wang; Michael Walsh; Anuradha Gopalan; Jinru Shia; Christina Tran; Fung Ying Man; Sean McBride; Mark Schattner; Liying Zhang; Martin R Weiser; Zsofia K Stadler
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

2.  Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis.

Authors:  Rossella Tricarico; Salvatore Cortellino; Antonio Riccio; Shantie Jagmohan-Changur; Heleen Van der Klift; Juul Wijnen; David Turner; Andrea Ventura; Valentina Rovella; Antonio Percesepe; Emanuela Lucci-Cordisco; Paolo Radice; Lucio Bertario; Monica Pedroni; Maurizio Ponz de Leon; Pietro Mancuso; Karthik Devarajan; Kathy Q Cai; Andres J P Klein-Szanto; Giovanni Neri; Pål Møller; Alessandra Viel; Maurizio Genuardi; Riccardo Fodde; Alfonso Bellacosa
Journal:  Oncotarget       Date:  2015-12-15

3.  Constitutional 2p16.3 deletion including MSH6 and FBXO11 in a boy with developmental delay and diffuse large B-cell lymphoma.

Authors:  N van Engelen; F van Dijk; E Waanders; A Buijs; M A Vermeulen; J L C Loeffen; R P Kuiper; M C J Jongmans
Journal:  Fam Cancer       Date:  2021-04-03       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.